DMIIR

DMIIR represents rights issued by Drugs Made In America Acquisition II Corp. These rights are derivative securities that typically allow holders to purchase additional shares at a predetermined price during a specified exercise period. Rights are often issued as part of a SPAC unit offering and can be traded separately from the common stock. The value of these rights depends on the underlying stock price and the terms of the exercise agreement. They provide existing shareholders with the opportunity to maintain their proportional ownership when new shares are issued.